Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000899243-22-035758

Chief Commercial Officer sold 2,702 shares at $60.03 ($162,201)

  • Chief Commercial Officer acquired 2,702 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Khayal Tamer I · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-11-11 Exercise or conversion : show line 1 in the form +2,702 $2.21 $5,971 4,002 D
2022-11-11 Sale : show line 2 in the form −2,702 $60.03 $162,201 1,300 D
Open-market sales · 2,702 sh · avg $60.03 · $162,201

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-11-11 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −2,702 15,305 D
Loading xslF345X03/doc4.xml…